Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Nilotinib for Lewy Body Dementia
Recruiting0 awardsPhase 2
Washington, District of Columbia
This trial tests if Nilotinib, a cancer drug taken as a pill, can help elderly patients with Dementia with Lewy Bodies by clearing harmful brain proteins. Nilotinib is part of a promising combination of medications shown to be effective against Alzheimer's disease.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service